Home » Akonni

Akonni

Jan 04, 2019

Akonni Biosystems Submits Multiplex Diagnostics System to FDA

Upon clearance of the platform, the company will commercialize the TruDiagnosis, an IVD system for genotyping multiple genes in a DNA sample, this year.

Aug 21, 2018

Akonni Biosystems Scores $3M NIH Grant for POC Dx Platform, Drug-Resistant TB Assay

The firm plans to make the molecular testing system accessible to low-income countries, in part by reducing costs using reel-to-reel manufacturing.

Mar 20, 2018

Akonni Biosystems Forms Chinese Commercialization Partnership with Righton

The exclusive two-way licensing deal also allows Akonni to commercialize Righton's molecular diagnostic tests outside of China.

Nov 14, 2017

Akonni Wins $300K NIH Grant for Drug-Resistant Tuberculosis Test

The grant was awarded under a program designed to help small businesses transition NIH-funded projects into the commercialization stage.

Aug 09, 2017

Akonni Biosystems Wins NIH SBIR Grant for Pediatric Respiratory Disease Diagnostics

The grant is specifically intended to support the development of noninvasive, rapid tests that can be used at the point of care in developing country settings.

May 15, 2017

Akonni Biosystems Raises $4M

The funding will be used in part to prepare an FDA submission for a clinical IVD pharmacogenomic test for its TruDx 2000 microarray platform.

Jan 09, 2015

Study Suggests Feasibility of Immune-Response Biomarker Panels to Detect Latent Tuberculosis

Premium

An RT-qPCR-based assay of antigen-stimulated blood is a possible next-gen approach for latent TB detection, a Cepheid executive noted in an accompanying commentary.

Jun 24, 2014

IP Roundup: Siemens, Affymetrix, Akonni, University of California, LLNL

Premium

Title: Biochip
Patent Number: 8,753,874
Filed: Dec. 15, 2003
Lead Inventor: Walter Gumbrecht, Siemens

Mar 13, 2014

Harvard, Akonni Partnership Wins $29M to Develop Drug-Resistant Tuberculosis Diagnostic

Premium

Harvard University and Akonni Biosystems have teamed up to develop and test an amplification array-based diagnostic for multi-drug-resistant and extreme-drug-resistant tuberculosis.

Mar 11, 2014

NIAID Awards $12.3M for Dx-Focused Translational Research Centers at Columbia, Harvard

NEW YORK (GenomeWeb News) – Harvard Medical School and Columbia University have both received grants from the National Institute of Allergy and Infectious Diseases, totaling $12.3 million this year, to create translational research centers to develop molecular diagnostics technologies.

Pages

The Scan

The Preliminary Investigation

Chinese state news agency Xinhua reports that a preliminary investigation has found He Jiankui performed his gene-editing work illegally.

John Mendelsohn Dies

John Mendelsohn, a former president of the University of Texas MD Anderson Cancer Center, has died, the New York Times reports.

Similar, But Not Quite the Same

Identical twins receive different estimates of ancestry from the same direct-to-consumer genetic testing firms, CBC reports.

This Week in PNAS

In PNAS this week: chromosomal features of maize, adaptations in the vinous-throated parrotbill, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.